TMCnet News
T2 Biosystems Reports Granting of Inducement AwardsLEXINGTON, Mass., Jan. 08, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on January 2, 2019 it issued inducement awards to six new employees. These awards were made under T2 Biosystems’ Inducement Award Plan (the "Inducement Plan"), which was adopted by the company’s Board of Directors on March 1, 2018 and provides for the granting of equity awards to new employees of T2 Biosystems. The inducement awards consist of options to purchase 21,500 shares of T2 Biosystems common stock and have a ten-year term. The exercise price of the options is $3.53, which was the per-share closing price of T2 Biosystems common stock on the Nasdaq Capital Marketon January 2, 2019. The options vest over a four-year period, with 25% vesting on the first anniversary of the employee’s date of hire and the remainder vesting in equal monthly installments over the three years thereafter. The award was approved by the independent compensation committee of T2 Biosystems’ board of directors and was granted as an inducement material to the new employee entering into employment with T2 Biosystems in accordance with Nasdaq Marketplace Rule 5635(c)(4). About T2 Biosystems: Media Contact: Investor Contact:
|